20 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jun 2037. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

Jun 2037

Next term end

Patent families

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039 204020412042204320442045

notable patents fee due within 90 days all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Notable

Nucleic Acid-Guided Nucleases US 9,982,279

The most cited patent in this portfolio, cited by 237 later US patents, top 1% of utility patents granted in 2018 in our data. Protection runs to 2037.

Ends Jun 2037 · High confidence Also notable

Nucleic Acid-Guided Nucleases US 10,011,849

Cited by 106 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2037.

Ends Jun 2037 · High confidence Also notable

Engineered Enzymes US 10,604,746

Cited by 11 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2039.

Ends Oct 2039 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Jan 2 to 11, 2027 · next Jan 2
1 fee due Apr 8, 2027
The maintenance fee for Nucleic Acid-Guided Nucleases (US 10,435,714) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
1 fee due Sep 30, 2027
The maintenance fee for Engineered Enzymes (US 10,604,746) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.
1 fee due Oct 21, 2027
The maintenance fee for Nucleic Acid-Guided Nucleases (US 10,626,416) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
1 fee due Nov 5, 2027
The maintenance fee for Engineered Enzymes (US 10,640,754) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Engineered Enzymes	7 in force	to Jan 2040
Nucleic Acid-Guided Nucleases (2017)	7 in force	to Jun 2037
Nucleic Acid-Guided Nucleases (2017)	5 in force	to Apr 2040
Engineered Enzymes and Bioproduction of Bakuchiol	1 in force	to Mar 2043

Patents held now

Soonest term end first.

Patent	Title	Status	Expires	Confidence
US 9,982,279	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 10,011,849	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 10,337,028	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 10,435,714	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 10,626,416	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 11,130,970	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 11,220,697	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 11,306,327	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · High confidence	In force	Term ends Jun 23, 2037	High confidence
US 11,408,012	Nucleic Acid-Guided Nucleases In force Term ends Jun 23, 2037 · Medium confidence	In force	Term ends Jun 23, 2037	Medium confidence
US 12,180,502	Nucleic Acid-Guided Nucleases In force Ends no later than Jun 23, 2037 · Medium confidence	In force	Ends no later than Jun 23, 2037	Medium confidence

10 of 20 patents shown.

Pro members see all 20.

Pro members: see all 20 patents

Also on record, not counted in the 20: 5 applications pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Manus Inscripta, Inc.